Vaccine trial
Top View
- Vaccine Clinical Trials and Data Infrastructure
- Current State of the First COVID-19 Vaccines
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices
- VAERS) Standard Operating Procedures for COVID-19 (As of 29 January 2021)
- Effectiveness of the Pfizer-Biontech and Oxford-Astrazeneca Vaccines
- COVID-19 Vaccine Frequently Asked Questions
- COVID-19 Mrna Vaccine FAQ
- Ethical Considerations for Current and Future COVID-19 Placebo-Controlled Vaccine Trials and Trial Unblinding Policy Brief 18 December 2020
- Reviewing Clinical Trials: a Guide for the Ethics Committee
- 2023 Before We Have Enough Doses for the Whole World
- CLINICAL CONSIDERATIONS for COVID-19 VACCINATION February 26, 2021 CONTINUING EDUCATION
- Thimerosal Timeline
- Clinical Study First Sub-Protocol
- WHAT HAPPENS AFTER a COVID-19 VACCINE TRIAL SUCCEEDS? Four Pharmacovigilance Challenges to Address During Commercialization
- Endpoints in Vaccine Trials
- FDA Briefing Document: Moderna COVID-19 Vaccine
- CDC Global Immunization Strategic Framework 2021-2030 with Immunization Agenda 2030 and Gavi 5.0
- Covid-19 Vaccine Trial Protocols Released